| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/11/2008 | EP1928235A2 Composition and method for use in cartilage affecting conditions |
| 06/11/2008 | EP1758612B1 Composition comprising intercalated functional-active organic compounds |
| 06/11/2008 | EP1751183A4 Fas associated factor 1 |
| 06/11/2008 | EP1750744B1 Medicament for the treatment of fungal infections, particularly aspergillosis |
| 06/11/2008 | EP1558737A4 Gene families associated with cancers |
| 06/11/2008 | EP1443816B1 Methods of treating disorders related to apoe |
| 06/11/2008 | EP1437969A4 Method, instruments, and kit for autologous transplantation |
| 06/11/2008 | EP1392846B1 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 06/11/2008 | EP1372621B1 Novel use of tyrosine kinase frk inhibitor |
| 06/11/2008 | EP1282436B1 Treatment of acute coronary syndrome with glp-1 |
| 06/11/2008 | EP1165113B1 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
| 06/11/2008 | EP1086137B1 Composition and method for modulating dendritic cell-t cell interaction |
| 06/11/2008 | EP0954529B1 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis |
| 06/11/2008 | EP0948538B1 Analysis and separation of platelet-derived growth factor proteins |
| 06/11/2008 | EP0948522B1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
| 06/11/2008 | EP0891551B1 Protein phosphatase-1 catalytic subunit interactions |
| 06/11/2008 | CN101198622A Polypeptides and use thereof |
| 06/11/2008 | CN101198357A Human granulocyte-colony stimulating factor isoforms |
| 06/11/2008 | CN101198350A Stable buffered, pharmaceutical compositions including motilin-like peptides |
| 06/11/2008 | CN101198349A Use of leptin for the prevention of excess body weight and composition containing leptin |
| 06/11/2008 | CN101198348A Bone morphogenetic protein formulations |
| 06/11/2008 | CN101198347A Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant molecules |
| 06/11/2008 | CN101198346A LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized |
| 06/11/2008 | CN101198345A LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized |
| 06/11/2008 | CN101198344A LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized |
| 06/11/2008 | CN101198343A Platelet-derived growth factor compositions and methods of use thereof |
| 06/11/2008 | CN101198321A Hematopoietic factor production promoter |
| 06/11/2008 | CN101198318A Antibiotique composition |
| 06/11/2008 | CN101198312A Pharmaceutical compositions and use thereof |
| 06/11/2008 | CN101195822A High-endophilicity targeting amalgamation protein |
| 06/11/2008 | CN101195799A SOD distillate spirits and manufacturing method thereof |
| 06/11/2008 | CN101195657A Type I cell factor receptor sample molecule, encoding gene and application thereof |
| 06/11/2008 | CN101195656A Recombined Japanese lamprey glandulae oris excreted L-250 protein anticoagulant efficacy |
| 06/11/2008 | CN101195027A Application of lysostaphin in preparing medicament for treating osteomyelitis |
| 06/11/2008 | CN101195026A Lactase granular formulation and method for preparing the same |
| 06/11/2008 | CN101195025A Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (tb4) analogues, isoforms and other derivatives |
| 06/11/2008 | CN101194889A Cyclosporin A nano-grain self-emulsifying freeze drying powder preparations and method for preparing the same |
| 06/11/2008 | CN100393747C Novel albumins |
| 06/11/2008 | CN100393746C Tumour antigen protein and tumour antigen peptide |
| 06/11/2008 | CN100393745C Tumour antigen protein and tumour antigen peptide |
| 06/11/2008 | CN100393742C Antibacterial tripeptides and modified chemicals, and application |
| 06/11/2008 | CN100393356C Modified cytokines for use in cancer therapy |
| 06/11/2008 | CN100393243C Nutritional compositions |
| 06/10/2008 | USRE40374 immunomodulators comprising interleukins, Flt-3 ligands, CD antigens, interferons, colony stimulating factors, nucleotides and proteins coded by such nucleotides, antibodies raised against such proteins, used to elicit immune responses in mammals |
| 06/10/2008 | US7386398 Hepatitis C Virus NS5B polymerase inhibitor binding pocket |
| 06/10/2008 | US7385045 Naturally-occurring variants of B7 proteins produced by alternative RNA splicing or alternative termination of full-length amino acid sequence; regulation of immune response in an animal; immunostimulants; anticarcinogenic agents, infections; antiallergens; antiinflammatory agents; veterinary medicine |
| 06/10/2008 | US7385044 Comprises nucleotide sequences coding fusion protein ligand which binds major histocompatibility complex and human leukocyte antigen for use in detection and prevention of infections, cancer andautoimmune disorders |
| 06/10/2008 | US7385036 cDNA moleculae codes a polypeptide in which at position 4, Phe is replaced with Tyr, at positon 5, Ala replaced with Val, at position 25, Lysine replaced with Arg, and at 45, Glu is replace with Gln; for use in diagnosis and treatment of atherosclerosis and inflammation; antiapoptosis |
| 06/10/2008 | US7385035 Cytotoxic protein and utilization thereof |
| 06/10/2008 | US7385034 Complementary DNAs encoding proteins with signal peptides |
| 06/10/2008 | US7385032 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 06/10/2008 | US7385031 PRO6097 polypeptides |
| 06/10/2008 | US7385030 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 06/10/2008 | US7385029 crystallizing amorphous N2-(N,N-dimethyl-L-valyl)-N-[(1 S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[(2-phenylethyl)amino]propyl]-1-pyrrolidinyl]-1-[(S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide (TZT-1027) or salts from diethyl ether or ethyl acetate or mixed solvent; stability |
| 06/10/2008 | US7385026 Modified ghrelin polypeptides |
| 06/10/2008 | US7385025 Comprising biologically active alpha-melanocyte stimulating hormone, gamma-melanocyte stimulating hormone, or bombesin sequence wherein residue comprising nitrogen atom and sulfur atom each available for complexation to metal ion is inserted between two and three position to c-terminus side of n position |
| 06/10/2008 | US7385024 For therapy of proliferative diseases (particularly cancer), acromegaly or diabetic nephropathies and retinopathies |
| 06/10/2008 | US7385023 Cancer immunotherapy and diagnosis using cytochrome P450 1B1 |
| 06/10/2008 | US7384982 e.g., disodium N-(5-chlorosalicyloyl)-8-amN-(10-[2-hydroxybenzoyl]amino)decanoate and disodium N-(10-[2-hydroxybenzoyl]amino)decanoate |
| 06/10/2008 | US7384942 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/10/2008 | US7384933 Derivatives of 2-hydroxytetrahydrofuran and their use as medicaments |
| 06/10/2008 | US7384918 Botulinum toxin for treating muscle contracture |
| 06/10/2008 | US7384917 oligopeptides having renin suppression, diuretic and/or vasodilator activity in mammals; treating congestive heart failure |
| 06/10/2008 | US7384916 Methods and compositions for preventing and treating aging or photodamaged skin |
| 06/10/2008 | US7384915 Administering a chimeric fusion protein of insulin chain B, and glutamate decarboxylase (GAD) 65 peptides |
| 06/10/2008 | US7384914 Night-time oral insulin therapy |
| 06/10/2008 | US7384913 Inducing oocyte activation by administering sperm perinuclear theca protein 34; interacts with tyrosine kinase; enhancing fertility; treating or diagnosing diminished fertility and abnormal spermiogenesis, providing contraception; identifying contraceptive and fertility-enhancing agents |
| 06/10/2008 | US7384912 Administering parathyroid hormone-related protein intermittently at a dosage of at least 500 mu g/day for at least one month,to increase bone mass densityat a rate of at least 1% per month; treating osteoporosis |
| 06/10/2008 | US7384911 Also for preventing and treating bacterial and fungal diseases in mammals; agricultural applications; |
| 06/10/2008 | US7384910 Peptide consisting of Leu-Ala-Phe-Val-Leu-Arg-Lys-amide having at least one D amino acid |
| 06/10/2008 | US7384909 Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents |
| 06/10/2008 | US7384908 Activity Dependent Neurotrophic Factor I polypeptide having as an an active core site the sequence: Ser-Ala-Leu-Leu-Arg-Ser-Ile-Pro-Ala; neurotrophic/neuroprotective activity; treating conditions associated with fetal alcohol syndrome |
| 06/10/2008 | US7384784 Pax-encoding vector and use thereof |
| 06/10/2008 | US7384775 Comprises nucleotide sequences coding surface localized streptococcal polypeptides for design of vaccines for prevention of non-systemic diseases such as otitis media; genetic vaccines |
| 06/10/2008 | US7384767 Nucleic acid encoding an interleukin-9 receptor variant |
| 06/10/2008 | US7384756 Methods for treating muscle diseases and disorders |
| 06/10/2008 | US7384752 Comprises membrane protein associated with neurons for treating brain disorders; antidepressant |
| 06/10/2008 | US7384655 Preparation of compositions to alleviate inflammation and oxidative stress in a mammal |
| 06/10/2008 | US7384645 Outer membrane vesicles from gram negative bacteria and use as a vaccine |
| 06/10/2008 | US7384643 genetically engineered to be incapable of expressing a native A41L protein; binds to chemokines in the CXC group. |
| 06/10/2008 | US7384641 A nucleic acid encoding an antigen(HIV gp12o or gp160) against which an immune response is desired in a HIV patient and a second component containing a nucleic acid encoding a chemokine, and a carrier |
| 06/10/2008 | US7384636 Which induce an antibody specific to cell surface protein antigen from Streptococcus; use in vaccine production and preventing dental caries |
| 06/10/2008 | US7384635 Protein variants of naturally occurring allergens |
| 06/10/2008 | US7384634 Polypeptide, Connective Tissue Growth Factor (CTGF), polynucleotides encoding CTGF and polynucleotides regulating CTGF expression. The invention also provides agents that modulate CTGF and therapeutic methods for using the agents |
| 06/10/2008 | US7384627 Antitumor agents with the use of HSV |
| 06/10/2008 | US7384418 Methods and devices for delivery of agents to breast milk ducts |
| 06/10/2008 | CA2423481C Isolated peptides which bind to hla-c molecules and uses thereof |
| 06/10/2008 | CA2358040C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 06/10/2008 | CA2345121C Pharmaceutical composition for the treatment of acute disorders |
| 06/10/2008 | CA2329768C Pharmaceutical composition comprising factor viii and neutral liposomes |
| 06/10/2008 | CA2286330C Anti-vegf antibodies |
| 06/10/2008 | CA2284107C Activation of peptides |
| 06/10/2008 | CA2250075C Methods for diagnosing and treating alzheimer's disease |
| 06/10/2008 | CA2227607C Penicillaminamide derivatives |
| 06/10/2008 | CA2191750C Virosome-mediated intracellular delivery of therapeutic agents |
| 06/10/2008 | CA2153756C Transport protein which effects the transport of cationic xenobiotics and/or pharmaceuticals, dna sequences encoding it and their use |
| 06/10/2008 | CA2129046C Opioid diarylmethylpiperazines and piperidines |
| 06/10/2008 | CA2113562C Poultry mycoplasma antigens, gene thereof and recombinant vectors containing the gene as well as vaccines utilizing the same |
| 06/05/2008 | WO2008067495A2 Chemotherapeutic conjugates and methods of use |
| 06/05/2008 | WO2008067270A1 Macrocyclic grb2 sh2 domain-binding inhibitors |